Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)

• Akshay Flora, MD, MMed,
• Richard Holland, MBChB,
• Annika Smith, MBBS,
• John W. Frew, MBBS, MMed, MS

Affiliations

Akshay Flora, MD, MMed

University of New South Wales, Sydney, Australia; Ingham Institute of Applied Medical Research, Liverpool, Australia

Richard Holland, MBChB

The Skin Hospital, Darlinghurst, Australia; Department of Rheumatology, Concord Repatriation General Hospital, Sydney, Australia

Annika Smith, MBBS

The Skin Hospital, Darlinghurst, Australia; Department of Dermatology, Westmead Hospital, Sydney, Australia

John W. Frew, MBBS, MMed, MS

University of New South Wales, Sydney, Australia; Ingham Institute of Applied Medical Research, Liverpool, Australia; Department of Dermatology, Liverpool Hospital, Sydney, Australia; Correspondence to: John W. Frew, MBBS, MMed, MS, Department of Dermatology, Liverpool Hospital, Suite 7, Level 1, 45-47 Goulburn St, Liverpool, NSW 2170, Sydney Australia.